umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Median and 5-year survival of patients with COPD stage IV: a Swedish prospective closed cohort study
Research & Development Unit of the Jämtland County Council (Sweden).ORCID iD: 0000-0002-1684-1301
2009 (English)Conference paper, Poster (with or without abstract) (Refereed)
Abstract [en]

Background and objective

The prevalence of COPD stage IV has been reported to 0.1-0.2%. Little is known about the survival in COPD stage IV. The study aim was to estimate the survival of patients with COPD stage IV .

Methods

A cross-sectional point-prevalence study was conducted 2005 to identify and describe all patients with physician-diagnosed COPD stage IV in the city of Östersund, Sweden (Stenfors Chest 2006). These 70 patients are monitored in a prospective closed cohort study. Their emergency and elective hospital visits are registered. The subjects are invited to an yearly out-patient check-up. The time point subjects were diagnosed with stage IV-disease is identified through retrospective analysis of medical records. Medical records and death certificates are used to identify date and place of death.

Results

The cohort consist of 41 females and 29 males. Mean age at diagnosis of stage IV-disease was 67.6 (SD 10.7) years. The cohort had a median survival time of 8.2 years and a 5-year survival of 69% after diagnosis of COPD stage IV.

Discussion

Patients diagnosed with COPD stage IV have an long median survival time. The cohort has a complete follow-up, but is biased towards patients with hospital-based diagnosis of COPD stage IV and subjects were identified through hospital-based medical records. The attention patients receive taking part in a prospective study may lead to better survival.

Place, publisher, year, edition, pages
2009.
National Category
Respiratory Medicine and Allergy
Research subject
Lung Medicine
Identifiers
URN: urn:nbn:se:umu:diva-96336OAI: oai:DiVA.org:umu-96336DiVA: diva2:764151
Conference
ERS Vienna 2009
Available from: 2014-11-18 Created: 2014-11-18 Last updated: 2014-11-18

Open Access in DiVA

No full text

Authority records BETA

Stenfors, Nikolai

Search in DiVA

By author/editor
Stenfors, Nikolai
Respiratory Medicine and Allergy

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 19 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf